Last 25 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Agilon Health, Inc.'s quarterly P/E stands at 1.1x, down 97.0% year-over-year — suggesting improving earnings relative to price.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -4.64 | 1.10 | — | — | — | 36.08 | — | — | — | — | — | — | — |
| — | -97.0% | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.32 | 0.02 | 0.05 | 0.07 | 0.17 | 0.29 | 0.13 | 0.28 | 0.45 | 0.39 | 1.57 | 1.58 | 1.66 |
| — | -92.0% | -64.6% | -73.3% | -62.4% | -25.0% | -91.8% | -82.4% | -72.7% | -83.8% | -34.7% | -54.2% | -49.8% | |
| P/B Ratio | 14.87 | 0.73 | 2.25 | 1.39 | 2.33 | 3.57 | 1.66 | 2.81 | 3.98 | 3.62 | 7.76 | 8.27 | 8.09 |
| — | -79.7% | +35.6% | -50.4% | -41.5% | -1.4% | -78.6% | -66.0% | -50.8% | -61.3% | +21.5% | -6.8% | +0.4% | |
| P/FCF | — | 1.60 | — | — | — | — | 48.98 | 60.76 | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | 0.51 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | 137.79 | — | — | — |
| — | — | — | — | — | — | — | — | — | -45.5% | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Agilon Health, Inc.'s operating margin was 0.3% in Q1 2026, up 10.2 pp QoQ and up 1.7 pp YoY. The trailing four-quarter average of -6.8% lags the current quarter, suggesting the recent improvement is above-trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -3.2% | — | -6.2% | -4.7% | -3.8% | 3.3% | -2.5% | -4.4% | 2.2% | 4.7% | -11.7% | 3.2% | 5.1% |
| — | — | -147.6% | -6.6% | -273.2% | -29.3% | +78.5% | -236.5% | -57.5% | -32.5% | -906.3% | -13.1% | +0.9% | |
| Operating Margin | -7.1% | 0.3% | -9.9% | -9.1% | -8.3% | -1.4% | -7.1% | -9.2% | -2.9% | -0.4% | -19.6% | -3.5% | -2.7% |
| — | +119.5% | -39.8% | +0.6% | -184.5% | -222.4% | +63.7% | -166.2% | -7.9% | -1229.8% | -95.3% | +18.6% | +13.8% | |
| Net Margin | -6.8% | 2.1% | -12.0% | -7.7% | -7.5% | 0.8% | -6.9% | -8.1% | -2.1% | -0.4% | -28.3% | -2.8% | -1.6% |
| — | +167.0% | -73.2% | +5.3% | -261.6% | +309.0% | +75.4% | -193.2% | -32.1% | -124.9% | -245.2% | +37.3% | +49.2% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -135.6% | 19.5% | -87.3% | -30.8% | -23.0% | 2.5% | -20.2% | -18.8% | -4.5% | -0.9% | -30.1% | -3.6% | -1.7% |
| — | +679.9% | -331.4% | -63.9% | -410.5% | +377.5% | +32.7% | -423.8% | -163.3% | -159.5% | -466.1% | -28.1% | +8.4% | |
| ROA | -27.0% | 2.2% | -13.2% | -6.7% | -5.7% | 0.7% | -5.5% | -5.5% | -1.4% | -0.3% | -11.5% | -1.4% | -0.7% |
| — | +226.9% | -138.2% | -20.5% | -318.0% | +321.0% | +51.8% | -307.2% | -85.0% | -136.1% | -262.3% | +17.9% | +33.7% | |
| ROIC | -203.2% | 9.8% | -144.8% | -43.7% | -25.5% | -4.6% | -20.6% | -18.7% | -5.3% | -0.9% | -17.7% | -3.9% | -2.9% |
| — | +313.7% | -601.9% | -133.7% | -379.9% | -417.2% | -16.7% | -374.2% | -81.0% | -2036.1% | -107.5% | +3.7% | +40.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Agilon Health, Inc.'s Debt/EBITDA ratio is 2.8x — at a moderate level that warrants monitoring. The current ratio has weakened 13.5% YoY to 1.04x, tightening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.29 | 0.17 | 0.29 | 0.12 | 0.10 | 0.08 | 0.09 | 0.08 | 0.07 | 0.07 | 0.08 | 0.06 | 0.06 |
| — | +97.0% | +211.2% | +58.8% | +48.1% | +20.6% | +18.0% | +28.6% | +17.9% | +42.9% | +56.6% | +17.2% | +12.2% | |
| Debt / EBITDA | — | 2.78 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.02 | 1.04 | 1.02 | 1.08 | 1.16 | 1.20 | 1.27 | 1.29 | 1.36 | 1.33 | 1.51 | 1.50 | 1.50 |
| — | -13.5% | -19.5% | -16.1% | -14.4% | -10.0% | -16.5% | -14.5% | -9.5% | -30.8% | -44.2% | -39.4% | -43.3% | |
| Quick Ratio | 1.02 | 1.04 | 1.02 | 1.08 | 1.16 | 1.20 | 1.27 | 1.29 | 1.36 | 1.33 | 1.51 | 1.50 | 1.50 |
| — | -13.5% | -19.5% | -16.1% | -14.4% | -10.0% | -16.5% | -14.5% | -9.5% | -30.8% | -44.2% | -39.4% | -43.3% | |
| Interest Coverage | -59.85 | 2.21 | -108.30 | -59.14 | -65.35 | -0.12 | -65.50 | -71.15 | -16.82 | 3.43 | -85.25 | -11.88 | -8.62 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 25 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AGL stock.
Agilon Health, Inc.'s current P/E is -4.6x. The average P/E over the last 1 quarters is 1.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Agilon Health, Inc.'s current operating margin is -7.1%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Agilon Health, Inc.'s business trajectory between earnings reports.